FDA Investigator Arindam Dasgupta, PhD
Arindam Dasgupta, PhD has inspections in 7 countries as of 22 Jun 2023. Arindam Dasgupta, PhD has collaborated with a combinined 3564 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
29
Last Inspection Date:
22 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India,
United Kingdom of Great Britain and Northern Ireland,
Germany,
France,
Canada,
Netherlands
Co-Investigator(s):
Ademola O Daramola,
Alanna Lmussawwir Bias,
Allen F Hall,
Amanda E Lewin, PhD,
Amber G Chung,
Ana P Barido,
Angela E Glenn,
Anh M Lac,
Anita R Michael,
Anna M Brannen,
Anthony N Onianwa,
Ashar P Parikh,
Azza Talaat,
Bonita S Chester,
Brandon L Mariner,
Brooke K Higgins,
Bruce H Mccullough,
Byungja E Marciante,
Candice C Mandera,
Candice C Mandero,
Candice J Cortes,
Carl Lee,
Carla J Lundi,
Carol Mrivera Lopez, PhD,
Carol Rivera Lopez, PhD,
CDR Rochelle B Young, RPh, MSA,
Charles A Snipes, PhD,
Charles R Bonapace, PhD,
Claire M Minden,
Comyar Shoghi,
Courtney N Long,
Craig A Garmendia,
Cynthia A Harris, MD, RN,
Cynthia White,
Daniel J Roberts,
Daniel L Aisen,
David K Glasgow,
David L Chon,
David R Heiar,
Dawn C Olenjack,
Dawn L Wydner,
Denise M Visco, Investigator,
Diane Cvan Leeuwen,
Dianne H Milazzo,
Dipesh K Shah,
Douglas Florentino,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Sriram Subramaniam, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin R Abaonza,
Elise A Murphy,
Erin M Mcdowell,
Farhana Khan,
Gajendiran Mahadevan, PhD,
Gene R Gunn,
Geoffrey K Kilili,
George C Amedro,
George J Flynn,
Gerald Mierle,
Geraldine D Sanders,
Gifford Whitehurst, Jr,
Gopa Bisivas,
Gulshan R Anand,
Hasan A Irier, PhD,
Hector J Colon Torres,
Huixia Zhang,
Ivis Lnegron Torres,
Jackie O'shaughnessy,
Jacqueline A O'shanghnessy, PhD,
Jacqueline A O'shaughnessy, PhD,
Jacqueline A Shaughnessy, PhD,
Jacqueline N O'shaughnessy,
Jane M Kreis,
Janete F Guardia,
Jaqueline A O'shaughnessy,
Jean M Kelahan,
Jeanne J Thai,
Jeffrey M Watson,
Jennifer Adams, MPH,
Jennifer C Adams,
Jennifer L Degroot,
Jennifer L Johnson,
Jennifer L Sheehan,
John A Iwen,
John A Kadavil, PhD,
Jonee J Mearns,
Joseph L Despins, PhD,
Jyoti B Patel, PhD,
Kara A Scheibner, PhD,
Karen M Cooper,
Katherine Szestypalow,
Kent A Conforti,
Kevin P Foley,
Kim Lthomas Cruse,
Kristin M Abaonza,
Lakisha M Williams,
Lance M De Souza, MBA,
LCDR Jennifer H Rhyu,
Lequita M Mayhew,
Linda M Cheny,
Linda R Kuchenthal,
Lisa B Orr,
M Patriciaurphy Murphy,
Marcus F Yambot,
Margaret M Sands,
Marie K Kinkade,
Marion W Nadeau,
Martin K Yau, PhD,
Martin K You,
Mary K Kinkade,
Mathew R Manen,
Matthew C Watson,
Matthew R Mcnew,
Melkamu Getie Kebtie, PhD,
Michael F Skelly, PhD,
Michael Serrano,
Mike M Rashti,
Minh D Phan,
Mohsen Rajabi Abhari, FDA,
Mra Mcculloughj,
Myra K Casey,
Nathaniel R Esaw,
Nebil A Oumer,
Nerizza B Dalena,
Nerizza B Guerin,
Nicola M Fenty Stewart,
Nilufer M Tampal, PhD,
Nina Yang,
Niraj R Mehta, PhD,
Patrick D Stone, MS,
Paula J Bretz,
Peter E Baker,
Regina T Brown,
Richard H Penta,
Robert C Steyert,
Robert L Lewis, Jr,
Roger F Zabinski,
Ronda R Loyd Jones,
Ruben C Ayala, PharmD,
Sam H Haidar, PhD,
Samantha J Pinizzotto, D V M,
Samuel H Chan, PharmD,
Sandra A Hughes,
Sandra S Saniga,
Scott B Laufenberg,
Sean Y Kassim, PhD,
Seongeun Cho (Julia), PhD,
Sharon K Thoma, PharmD,
Sharon K Thomas,
Sherry I Seerist,
Sherry L Secrist, BLT DO,
Srinivas R Chennamaneni, PhD,
Sripal R Mada, PhD,
Stacey A Priest,
Stacey S Degarmo,
Stanley Au,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Steven P Donald,
Susanne M Richardson, MSc RAC ELS,
Taichun Qin, PhD,
Tamal K Chakraborti, PhD,
Terrance L Thomas,
Thea C Grome,
Thomas W Gordon,
Tiara Nbrown Crosen,
Tiffani D Wilson,
Timothy C Grome,
Torrance J Slayton,
Tracey L Harris,
Uttaniti Limchumroon (Tom),
Vickie J Kanion,
Walden H Lee,
William H Linkroum,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Xingfang Li, MD,
Yanming An, PhD,
Yih Chain Huang, PhD,
Young M Choi, PhD,
Young M Yoon,
Yumi J Hiramine,
Yvins Dezan
Arindam Dasgupta, PhD's Documents
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more